Home/Biostate AI/Kutapa Muthanna
KM

Kutapa Muthanna

CEO, Bayosthiti AI (India Subsidiary)

Biostate AI

Biostate AI Pipeline

DrugIndicationPhase
MARE DNAseq for Newborn Screening5,000+ Inherited Genetic DiseasesDevelopment
RNAseq (BIRT+PERD) PlatformBroad Transcriptomic Analysis for Disease PredictionDevelopment/Service
AML (N-Act) AIAcute Myeloid LeukemiaDevelopment
K-Dense Autonomous ResearchBroad Scientific DiscoveryResearch